These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16463710)

  • 1. [The beta2-adrenergic receptor agonists in the treatment of chronic obstructive pulmonary disease].
    Chorostowska-Wynimko J
    Przegl Lek; 2005; 62(7):724-8. PubMed ID: 16463710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases].
    Płusa T
    Pol Merkur Lekarski; 2010 Jan; 28(163):8-12. PubMed ID: 20369715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New beta2-agonists in asthma and COPD].
    Chyrek-Borowska S; Rogalewska AM
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():58-61. PubMed ID: 12580164
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
    Cazzola M; Matera MG
    Pulm Pharmacol Ther; 2003; 16(4):197-201. PubMed ID: 12850121
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease and panic disorder: their interrelationships and a unique utilization of beta-receptor agonists.
    Harvey H; Hayashi J; Speigel DR
    Psychosomatics; 2008; 49(6):546. PubMed ID: 19122136
    [No Abstract]   [Full Text] [Related]  

  • 8. Formoterol (Perforomist) for COPD.
    Med Lett Drugs Ther; 2007 Nov; 49(1274):94-5. PubMed ID: 18007544
    [No Abstract]   [Full Text] [Related]  

  • 9. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies.
    Rabe KF
    Proc Am Thorac Soc; 2006 May; 3(3):270-5. PubMed ID: 16636097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-acting beta2-agonist bronchodilators safety for asthma treatment].
    Giubergia V
    Arch Argent Pediatr; 2009 Aug; 107(4):291-3. PubMed ID: 19753432
    [No Abstract]   [Full Text] [Related]  

  • 13. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists.
    Santus P; Centanni S; Morelli N; Di Marco F; Verga M; Cazzola M
    Respir Med; 2007 Aug; 101(8):1798-803. PubMed ID: 17399972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease.
    Berger WE; Nadel JA
    Respir Med; 2008 Feb; 102(2):173-88. PubMed ID: 18023995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arformoterol (Brovana) for COPD.
    Med Lett Drugs Ther; 2007 Jul; 49(1264):53-5. PubMed ID: 17595597
    [No Abstract]   [Full Text] [Related]  

  • 17. Are beta2-agonists safe in patients with acute exacerbations of COPD?
    Joos GF
    Am J Respir Crit Care Med; 2007 Aug; 176(4):322-3. PubMed ID: 17675449
    [No Abstract]   [Full Text] [Related]  

  • 18. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
    Wang J; Nie B; Xiong W; Xu Y
    J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation.
    Patel M; Thomson NC
    Expert Opin Pharmacother; 2012 May; 13(7):1069-75. PubMed ID: 22364295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.